Advertisement
Screener

PASITHEA THERAPEUTICS CORP. (KTTA) Cash

2.8 / 5 stars · 68/120 Roast Me

PASITHEA THERAPEUTICS CORP. Cash

PASITHEA THERAPEUTICS CORP. (KTTA) had Cash of $26.60 million as of 2023-06-30, per its 10-Q filed 2023-08-11.

Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments

us-gaap:Cash · last filed 2023-08-11

  • 2023-06-30: Cash $26.60M.
  • 2023-03-31: Cash $29.90M.
  • 2022-12-31: Cash $1.00M.
  • 2020-12-31: Cash $247.14K.
Period endCash
2023-06-30$26.60M
10-Q · filed 2023-08-11
2023-03-31$29.90M
10-Q · filed 2023-05-12
2022-12-31$1.00M
10-K · filed 2023-03-30
2020-12-31$247.14K
10-K · filed 2022-03-30
2020-09-30$247.14K
10-Q · filed 2021-11-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Lipocine Inc. (LPCN)United States$0.017B-1.79
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Rocket One Inc. (RKTO)United States$0.019B